Related Experiment Video
Updated: Jan 17, 2026
Visualization of Streptococcus pneumoniae within Cardiac Microlesions and Subsequent Cardiac Remodeling
Published on: April 7, 2015
Risk of Major Adverse Cardiovascular Events During Acute Streptococcus pneumoniae Infection in COPD Patients
Nicoline Meyer Riisberg1, Daniel Modin2, Barbara Bonnesen Bertelsen1
1Section of Respiratory Medicine, Department of Medicine, Herlev and Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
Background:
Patients with chronic obstructive pulmonary disease (COPD) are at an increased risk of severe complications and death from community-acquired pneumonia such as Streptococcus pneumoniae. Previous studies suggest that acute infection heightens the short-term risk of cardiovascular events.
Objectives:
This study investigates the risk of major adverse cardiovascular events (MACE) during the acute phase of S pneumoniae infection in patients with COPD.
Methods:
We conducted a self-controlled case series study in patients with COPD and a positive lower respiratory tract or blood culture for S pneumoniae between 2010 and 2017 using Danish Nationwide register data. The primary outcome was incidence of MACE and the risk interval was defined as the first 14 days after an airway or blood culture positive for S. pneumonia. The control interval was defined as 180 days before and 180 days after the risk interval. Statistical analysis involved conditional Poisson regression models to calculate incidence rate ratios.
Results:
We identified 327 patients with a positive culture for S pneumoniae, who experienced a MACE during the study period. Sixty patients died during the study period leaving 267 patients for analysis. Pneumococcal infection was associated with a 4.6-fold increased incidence of MACE (P < 0.001) within 14 days after the infection and a 9.1-fold increased incidence of acute myocardial infarction (P < 0.001).
Conclusions:
Pneumococcal infection in patients with COPD was associated with an increased risk of MACE within 14 days postinfection. Further studies should address whether preventative interventions could mitigate risks in patients with COPD and pneumococcal infections.
More Related Videos
11:32Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
Published on: February 23, 2014
04:03Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
Related Concept Videos
01:30Pneumonia I: Introduction
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
01:22Chronic Obstructive Pulmonary Disease
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
01:30Pneumonia III: Complications and Assessment
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
01:20COPD: Pathogenesis and Clinical Features
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
01:29Pneumonia II: Pathophysiology